InvestorsHub Logo
Followers 31
Posts 3409
Boards Moderated 0
Alias Born 02/09/2017

Re: bow-tie post# 8152

Tuesday, 08/21/2018 12:17:30 PM

Tuesday, August 21, 2018 12:17:30 PM

Post# of 27660
€22.5M to Develop a Universal Flu Vaccine

MEDICAL

?

BY CLARA RODRÍGUEZ FERNÁNDEZ16/01/2018 08:00

Vaccitech has closed a Series A fundraising that will support clinical trials with its vaccine technology against influenza and prostate cancer.
Spun out from Oxford University in 2016, Vaccitechhas now closed its Series A fundraising round. Amounting to a total of £20M (€22.5M), the round was co-led by GV, Oxford Sciences Innovation and Sequoia China, and joined by Neptune Ventures.
The company plans to use the cash to complete two Phase II trials, testing vaccines for flu and prostate cancer, by 2019. It will also fund the research necessary to take three other vaccine programs to the clinic.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News